McIntyre Gail Frances 4
4 · Aravive, Inc. · Filed Apr 9, 2020
Insider Transaction Report
Form 4
Aravive, Inc.ARAV
McIntyre Gail Frances
Chief Scientific Officer
Transactions
- Award
Stock Option
2020-04-08+80,000→ 80,000 totalExercise: $6.16From: 2020-05-08Exp: 2030-04-07→ Common stock (80,000 underlying)
Footnotes (1)
- [F1]These options vest pro rata on a monthly basis over four (4) years commencing on May 8, 2020, the one month anniversary of the grant date.